Fish oil supplementation in type 2 diabetes: A quantitative systematic review

Diabetes Care

Volumn 23, Issue 9, 2000, Pages 1407-1415

  Montori, V M ^a   Farmer, A ^a   Wollan, P C ^a   Dinneen, S F ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL;

CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; FAT INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033851158     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.9.1407     Document Type: Review

References (86)

1. Lipoprotein metabolism in diabetes mellitus
2. Management of dyslipidemia in adults with diabetes (Position Statement)
3. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study
4. Cardiovascular outcomes in type 2 diabetes: A double-blind placebo-controlled study of bezafibrate: The St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study
5. Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus
6. Adverse metabolic effect of omega-3 fatty acids in non-insulin dependent diabetes mellitus
7. Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes
8. Diabetes mellitus in Eskimos
9. The composition of food consumed by Greenland Eskimos
10. Suppression by diets rich in fish oil of very low density lipoprotein production in man
11. Effects offish oil on VLDL triglyceride kinetics in humans
12. Treatment of diabetic dyslipidemia
13. Hyperlipidemia and diabetes mellitus
14. Identifying relevant studies for systematic reviews
15. Comparison of percent total GHb with percent HbA(1c) in people with and without known diabetes
16. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
17. Bias in meta-analysis detected by a simple, graphical test
18. Effect of glyburide and omega 3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus
19. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM: A randomized controlled study
20. Vitamin E and the susceptibility of erythrocytes and reconstituted liposomes to oxidative stress in aged diabetics
21. Lower prevalence of impaired glucose tolerance and diabetes associated with daily seal oil or salmon consumption among Alaska Natives
22. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy
23. Essential fatty acid metabolism in south Indians
24. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease
25. Eicosanoid precursors: Potential factors for atherogenesis in diabetic CAPD patients?
26. Is it time for a clinical trial of dietary fish oil supplementation in individuals with NIDDM?
27. Fish oil, essential fatty acids, and hypertension
28. Fish consumption and cardiovascular disease in the Physicians' Health Study: A prospective study
29. Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans
30. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus
31. Do n-3 fatty acids improve glucose tolerance and lipemia in diabetics?
32. Indications for lipid-lowering drugs: Unanswered questions
33. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients
34. Biological effects of omega-3 fatty acids in diabetes mellitus
35. Effect of fish oil concentrate on the lipoprotein profile of patients with type II diabetes mellitus
36. The effects of short-term omega-3 polyunsaturated fatty acid supplementation in patients with chronic renal insufficiency
37. Fish oils and their possible role in the treatment of cardiovascular diseases
38. Effect of high fiber intake in fish oil-treated patients with non-insulin-dependent diabetes mellitus
39. The triglyceride lowering effect of fish oils is affected by fish consumption
40. Experience with fish oil treatment with special emphasis on diabetic nephropathy
41. Effects of fish oils in patients with type 2 diabetes with associated dyslipidaemia
42. Effects of eicosapentaenoic acid on glycemic control and lipid metabolism in healthy and NIDDM subjects
43. Fish oil and glycemic control in diabetes: A meta-analysis
44. Dose response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia
45. Long-term effects of n-3 fatty acids on serum lipids and glycaemic control
46. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance
47. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia
48. Fish oil in diabetic nephropathy
49. Supplementation with olive oil rather than fish oil increases small arterial compliance in diabetic patients
50. Reduction in microalbuminuria in diabetics by eicosapentaenoic acid ethyl ester
51. Evaluation of an omega-3 fatty acid supplement in diabetics with microalbuminuria
52. Lipid peroxidation, LDL glycosylation and dietary fish oil supplementation in type II diabetes mellitus
53. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia
54. Effect of fish oil supplementation on insulin secretion and insulin action in type II (non-insulin-dependent) diabetic patients
55. Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus
56. Primary nitrate tolerance in diabetes mellitus
57. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus
58. Long-term effects (six months) of omega-3 polyunsaturated fatty acids on insulin sensitivity and lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia
59. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients
60. Effect of eicosapentaenoic acid ethyl on urine albumin excretion in NIDDM
61. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM: A randomized crossover study
62. Effect of eicosapentaenoic acid and docosahexaenoic add on diabetic osteopenia
63. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations
64. N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance: Italian Fish Oil Multicenter Study
65. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus
66. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM
67. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus
68. Effect of fish oil concentrate on lipoprotein composition in NIDDM
69. Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients
70. A comparison of fish oil or corn oil supplements in hyperlipidemic subjects with NIDDM
71. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes
72. Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus
73. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ametiorate the lipid profile in type 2 diabetic men: Results of a controlled study
74. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients
75. The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control
76. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM
77. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM: A randomized, prospective, double-blind, controlled study
78. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients
79. Metabolic and haemostatic consequences of dietary fibre and N-3 fatty acids in black type 2 (NIDDM) diabetic subjects: A placebo controlled study
80. Effects of fish oil supplements in NIDDM subjects: Controlled study
81. Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus
82. Importance of n-3 fatty acids in health and disease
83. Apolipoprotein B metabolism in hypertriglyceridemic patients administered either a fish oil- or vegetable oil-enriched diet
84. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages